5 things to know before the stock market opens Monday, June 27

5 things to know before the stock market opens Monday, June 27

Here are the most important news items that investors need to start their trading day: 1. Stocks look to build off last week’s rebound A trader works on the floor of the New York Stock Exchange (NYSE) in New York City, US, June 22, 2022. Brendan Mcdermid | Reuters US stock futures rose before the … Read more

FDA bans Juul e-cigarettes as US cracks down on nicotine products

The Food and Drug Administration announced Thursday that it will ban the sale of Juul e-cigarettes in the US The decision is part of the agency’s broader review of the vaping industry following years of pressure from politicians and public health groups to regulate the segment as strictly as other tobacco products after vaping became … Read more

5 things to know before the stock market opens Tuesday, June 21

Here are the most important news, trends and analysis that investors need to start their trading day: 1. Wall Street set to bounce after S&P 500’s worst seek since 2020 The sign for Wall Street is seen with US flags outside the New York Stock Exchange. Yuki Iwamura | afp | Getty Images Dow futures … Read more

5 things to know before the stock market opens Friday, June 17

Here are the most important news, trends and analysis that investors need to start their trading day: 1. Wall Street set to bounce but still tracking for a terrible week Traders on the floor of the NYSE, June 16, 2022. Source: NYSE US stock futures on Friday pointed to a strong open on Wall Street. … Read more

Covid vaccine for kids under 5 moves closer to FDA authorization after committee backs shots

A kindergarten student gives the thumbs up to her teacher before starting the first day of kindergarten at Laguna Niguel Elementary School in Laguna Niguel, CA on Tuesday, August 17, 2021. Paul Bersebach | MediaNews Group | Getty Images Moderna’s Covid-19 vaccine for infants through preschoolers has moved a step closer to authorization by the … Read more

FDA committee recommends Modern two-dose Covid vaccine for kids ages 6 to 17

A young man receives his Covid-19 vaccination at a vaccination clinic. People receive the Moderna vaccine in Milford, Pennsylvania. Preston Ehrler | LightRocket | Getty Images Moderna’s two-dose Covid-19 vaccine for kids ages 6 through 17 received the endorsement from the Food and Drug Administration’s committee of independent immunization experts on Tuesday, a key step … Read more

5 things to know before the stock market opens Tuesday, June 14

Here are the most important news, trends and analysis that investors need to start their trading day: 1. Wall Street set to rise after S&P 500 officially closed in bear market Traders on the floor of the NYSE, June 13, 2022. Source: NYSE US stock futures bounced after Tuesday’s cooler inflation report and what could … Read more

5 things to know before the stock market opens Friday, June 10

Here are the most important news, trends and analysis that investors need to start their trading day: 1. Wall Street turns decisively lower after another hot inflation report Traders work on the floor of the New York Stock Exchange NYSE US stock futures turned sharply lower after Friday’s before-the-bell inflation report showed a bigger-than-expected increase. … Read more

Novavax vaccine clears key step on path to FDA authorization

Novavax’s two-dose dose Covid-19 vaccine for adults ages 18 and older cleared a key step on the path toward Food and Drug Administration authorization on Tuesday. The FDA’s committee of independent vaccine experts voted 21 to 0 with one abstention to recommend authorization of the shot for use in the US after an all-day public … Read more

Novavax faces high-stakes FDA review this week that will decide the fate of its Covid vaccine in the US

In this photo illustration the Food and Drug Administration (FDA) and Novavax logos are seen behind a medical syringe and vials. Pavlo Gonchar | LightRocket | Getty Images Novavax’s Covid-19 vaccine will face the scrutiny of the Food and Drug Administration’s independent immunization experts this week, a crucial step on the path toward US regulatory … Read more